MESO Earnings & Financial Statements
Mesoblast Limited
$13.95
+$0.16(+1.16%)
40
Overall
60
Value
10
Tech
52
Quality
Market Cap
$1.79B
Volume
237.27K
52W Range
$13.05 - $21.50
Target Price
$37.00
MESO earnings and financial statements: Mesoblast Limited's income statement, balance sheet and cash flow statement, annual and quarterly.
MESO Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $17.20M | $5.90M | $7.50M | $10.21M | $7.46M |
| Cost of revenue | $5.13M | - | - | $17.29M | - |
| Operating income | -$58.99M | -$61.36M | -$68.55M | -$39.89M | -$45.56M |
| EBITDA | -$78.84M | -$71.84M | -$71.00M | -$91.59M | -$101.17M |
| Net income | -$102.14M | -$95.04M | -$95.02M | -$91.35M | -$100.35M |
| EPS (diluted) | $-0.85 | $-0.89 | $-105.30 | $-0.14 | $-0.16 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $784.68M | $669.15M | $731.33M | $662.14M | $744.72M |
| Total liabilities | $187.24M | $188.80M | $167.58M | $165.10M | $1.39B |
| Shareholders’ equity | $597.44M | $480.36M | $501.84M | -$738.92M | -$647.57M |
| Cash and equivalents | $161.55M | $62.96M | $70.92M | $60.45M | $136.88M |
| Long-term debt | $71.32M | $102.44M | $106.48M | $98.70M | $49.53M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$49.95M | -$48.46M | -$63.27M | -$65.78M | -$100.75M |
| Capital expenditure | - | - | - | -$75.0K | - |
| Free cash flow | -$50.63M | -$48.73M | -$63.53M | -$65.86M | -$100.75M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MESO | $13.95 | +1.2% | 237.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |